- C Raina MacIntyre
, professor1, - Abrar A Chughtai
, senior lecturer2, - Mohana Kunasekaran
, research associate1, - Essa Tawfiq
, research associate1, - Trish Greenhalgh
, professor of primary care health sciences3
- 1Biosecurity Program, The Kirby Institute, Faculty of Medicine and Health, University of New South Wales, Sydney, Australia
- 2School of Population Health, Faculty of Medicine and Health, University of New South Wales, Sydney, Australia
- 3Nuffield Department of Primary Care Health Sciences, University of Oxford, Oxford, UK
- Correspondence to: A A Chughtai abrar.chughtai{at}unsw.edu.au
Abstract
The covid-19 pandemic saw frequent changes and conflicts in mask policies and politicization of masks. On reviewing the evidence, including studies published after the pandemic, the data suggest respirators are more effective than masks in healthcare, but must be continuously worn to be protective. Healthcare and aged care settings amplify outbreaks, so protection of patients and staff is paramount. Most guidelines assume risk is only present during close contact or aerosol generating procedures, but studies show intermittent use of respirators is not protective. New research in aerosol science confirms the risk of infection is widespread in health facilities. In community settings, any mask use is protective during epidemics, especially if used early, when combined with hand hygiene, and if wearers are compliant. Community use of N95 respirators is more protective than surgical masks, which are more protective than cloth masks, but even cloth masks provide some protection. Mask guidelines should be adaptable to the specific context and should account for rising epidemic activity, and whether a pathogen has asymptomatic transmission. The main rationale for universal masking during pandemics is asymptomatic transmission, which means risk of transmission cannot be self-identified. The precautionary principle should be applied during serious emerging infections or pandemics when transmission mode is not fully understood, or vaccines and drugs are not available. If respirators are not available, medical or cloth masks could be used as a last resort. Data exist to support extended use and reuse of masks and respirators during short supply. In summary, extensive evidence generated during the covid-19 pandemic confirms the superiority of respirators and supports the use of masks and respirators in the community during periods of high epidemic activity. Some gaps in research remain, including economic analyses, research in special population groups for whom masking is challenging, and research on countering disinformation.
Introduction
The covid-19 pandemic put masks in the spotlight, with guidelines that were conflicting and rapidly changing. In early 2020, the World Health Organization initially recommended that masks be used only by people who had respiratory symptoms, but actively discouraged their use by healthy people.1 Advice from WHO, the United States Centers for Disease Control and Prevention (CDC), and other agencies changed several times during the pandemic, and at times swung between discouraging masks to suggesting N95 masks could be used in the community (fig 1).25 There was widespread disinformation and politicization of masks, with masks becoming a symbol of government control and oppression.2627 Yet early in a pandemic, when drugs and vaccines are unavailable, masks are among the few available protective measures, especially for frontline workers.282930313233
Changes in guidelines on use of facemasks and respirators throughout covid-19 pandemic. Guidance from: World Health Organization (WHO),234567891011 United States Centers for Disease Control and Prevention (CDC),12131415161718192021 and Public Health England—changed to UK Health Security Agency (HSA) in April 2021222324
Masks and respirators reduce transmission of respiratory infections34 by protecting the uninfected wearer and by blocking exhaled infectious particles from infected wearers (source control). Masks designed for healthcare use (medical or surgical masks) are water resistant, fit loosely around the face allowing unfiltered air to pass through the gaps around the edges, and their filtration efficacy might be variable.35 Cloth masks are widely used in low income countries and during shortages of medical masks, such as during the early months of the covid-19 pandemic, yet were not mentioned in any WHO policy document at the start of the covid-19 pandemic.36 Respirators are designed for occupational protection and provide superior protection through high grade filtration and a tight seal around the face.3437 Respirators, including disposable filtering facepiece respirators and reusable forms (elastomeric or powered air purifying respirators),3839 are mainly used in healthcare settings and require fit testing.4041424344 Some types of powered air purifying respirators do not require fit testing because they have a hood over the entire face and head instead of a face piece. These respirators are the most suitable for long, continuous use in high risk settings.
In our previous BMJ review,34 we examined evidence from randomized controlled trials (RCTs) of masks. Since then, three further RCTs in healthcare,454647 two in community settings,4849 and three as source control505152 have been published. A 2023 Cochrane review was interpreted by some to have shown that masks “do not work,”28 forcing Cochrane to issue an apology and clarification.53 The aim of this review is to summarize the current evidence around the protection provided by masks and respirators in healthcare and community settings, and how this evidence aligns with current policy.
Methods
We conducted a state of the art review examining the evidence on the effectiveness of masks and respirators in healthcare, community, and special settings. Articles were identified from PubMed (from January 1950 to 31 December 2023), Embase (from 1988 to 31 December 2023), Cochrane Library, Web of Science, and Google Scholar. The Australian New Zealand Clinical Trials Registry (ANZCTR) and the US National Institutes of Health clinical trial registry were also searched. Only English language publications were included. We used the following keywords for the search: “facemask,” “mask,” “surgical mask,” “medical mask,” “cotton/cloth mask,” “respirator,” “N95/N97, N99 respirator,” “FFP2/FFP3 respirator,” “P2/P3 respirator,” “respiratory protection,” “respiratory protective device,” “infection control,” “respiratory infections and facemasks/mask/respirator,” “influenza and facemasks/mask/respirator,” “flu and facemasks/mask/respirator,” “SARS-CoV2”/“covid-19”/“coronavirus disease,” “pandemic influenza and facemasks/mask/respirator,” “SARS and facemasks/mask/respirator,” “tuberculosis and facemasks/mask/respirator,” “TB and facemasks/mask/respirator,” “Ebola”/“Ebola virus Diseases,” and “emerging infections and facemasks/mask/respirator.” The GRADE (Grading of Recommendations Assessment, Development and Evaluation) approach was used to examine the type of evidence.54 RCTs were considered level 1 (high) evidence, observational studies (cohort, case-control, before-after, time series, case series, and case reports) were considered level 2 (low), and any other evidence was considered level 3 (very low) evidence.54 AAC reviewed the titles of publications identified by our searches and prepared an initial list of articles to be included in the study. Then CRM and AAC independently reviewed the abstracts of these articles and selected those suitable for inclusion. A separate search of the same databases was conducted by MK to identify meta-analyses of masks. A total of 29 studies were reviewed by all the authors and are summarized in supplementary table S1.282930313254555657585960616263646566676869707172737475767778 Only studies classed as high level (RCTs) have been included, and we give specific limitations for each RCT.
We also searched infection control policies and guidelines from WHO, the US CDC, the UK Health Security Agency, and other health organizations to identify recommendations on the use of masks and respirators, with a focus on changing policies over the course of the pandemic. Additionally, we searched health organization websites and Google for policies and guidelines on the use of masks and respirators. Only English language literature was reviewed. Key terms used in our search were “Infection control guideline/policy/plan,” “COVID-19 guideline/policy/plan,” “Ebola control guideline/policy/plan,” “Pandemic influenza guideline/policy/plan,” “Personal protective equipment use/guideline,” “Personal protective equipment use/guideline for infection control,” “Masks use/guideline for infection control,” “Respirator use/guideline for infection control.”
Previous meta-analyses on masks and respirator use
Meta-analyses of masks have reported conflicting results (online supplementary table S1). Some of these meta-analyses included only RCTs,555657 while others included RCTs and observational studies.58596061 Some meta-analyses found mask use to be protective596263 and others did not,5861 reflecting varied methods and data selection procedures. The most definitive study to date found substantial heterogeneity in the settings, interventions, and measurement of outcomes of RCTs, and identified important flaws in some meta-analyses.32 These flaws included combining dissimilar outcomes (such as differing clinical case definitions or laboratory diagnostics—eg, polymerase chain reaction (PCR) and serological testing) and dissimilar settings (such as healthcare and community).79 A positive PCR test is a rarer but more reliable outcome80 than a positive serological test, yet serological testing accounted for most primary outcome measures in some trials.478182 One meta-analysis corrected for this by combining only similar outcomes.32
Use of masks and respirators in healthcare settings
RCTs in healthcare settings
We identified seven RCTs comparing the efficacy of masks with that of respirators in healthcare settings. Six were conducted before the covid-19 pandemic and one during the pandemic.33454780818283 These trials used different interventions and some of them measured different outcomes. Table 1 presents details of study design, interventions, results, and risk of biases.
Summary of high level evidence by GRADE guidelines—clinical trials on facemasks or respirators in healthcare setting (adapted and summarized from Greenhalgh et al32 under Creative Commons license)
A key design issue was whether healthcare workers in the respirator arm of the trial wore their device continuously throughout a shift or whether they wore it only when undertaking what was assumed to be a high risk procedure (so-called targeted or intermittent use of respirators). A recent meta-analysis that separately analyzed continuous and targeted use of respirators found that respirators were considerably more effective than masks if worn continuously.32 Intermittent use of respirators or medical masks only when performing high risk procedures was not protective. Three North American trials found no difference in efficacy between masks and respirators when used intermittently for aerosol generating procedures or treatment of patients with known infection.478182 These findings are consistent with those of a trial in China that compared medical masks, intermittent use of N95 respirators, and continuous use of N95 respirators; this study showed no difference in efficacy between intermittent N95 respirators and medical masks, but considerably greater protection from continuous N95 use.3380
The superiority of N95 respirators over medical masks has also been shown against a range of viral and bacterial respiratory infections.85 These findings suggest that these infections are likely transmitted through inhalation of contaminated air86 because medical masks (designed to stop splash or spray of liquid) were not sufficiently protective. Airborne transmission of common respiratory infections means that the risk of transmission is likely to be widespread throughout health facilities owing to ventilation systems mixing and dispersing air,32 and calls into question many guidelines suggesting risk is only present during close contact or aerosol generating procedures.87
Healthcare facilities and many buildings use heating, ventilation, and air conditioning systems, which can draw in fresh air and might filter the air, are designed primarily for climate control. These systems use ducts to disperse air throughout a building, so human respiratory aerosols generated in one part of a building might be dispersed to another. In reality, infectious airborne particles accumulate and disperse widely in an indoor setting,88 posing a risk to people distant from the source of infection.89
When the covid-19 pandemic began, one RCT had been published comparing cloth masks with single use medical masks in a healthcare setting in Vietnam.45 The incidence of the primary outcome (influenza-like illness) was significantly higher in participants in the cloth mask arm (relative risk 13.00, 95% confidence interval 1.69 to 100.07), but there was no significant difference between arms for laboratory confirmed infection. The study was conducted in a setting where many participants washed their cloth masks by hand in cold water. A further post hoc analysis conducted in 2020 of data from that 2011 trial (after widespread concern about the safety of cloth masks) showed that if cloth masks were washed in a washing machine, their performance was similar to medical masks.90 WHO has since issued a recommendation for washing cloth masks after use at 60°C.91
Observational, case-control, cohort, and experimental studies in healthcare settings
A range of evidence exists from cohort,92 case-control,93949596979899 cross sectional,100101102103104105 laboratory experimental,106107108109110111112 and other epidemiological (including time series, modeling, and case series) studies.113114115116117118119120121122 Some of these studies were conducted during the SARS outbreak,949596979899103104105113116117118119123 others examined transmission of tuberculosis,121124125 respiratory syncytial virus,92 and pertussis.102 A systematic review and meta-analysis performed in early 2020 using observational data from SARS, Middle East respiratory syndrome (MERS), and early data on SARS-CoV-2 showed 85% protection from medical masks or respirators (analyzed together) in all settings combined, with greater protection in the healthcare setting, attributed to increased N95 use.69 In a subanalysis, respirators were 96% effective compared with masks, which were 67% effective.69
Respirators are recommended as source control for people with tuberculosis,121124125 but no studies could be found that measured their clinical efficacy in preventing tuberculosis.126 One study in South Africa found that use of masks as source control by patients with multidrug resistant tuberculosis greatly reduced airborne transmission to guinea pigs exposed to ward air.127 Additionally, an observational study found medical masks protect against nosocomial transmission of pertussis.102 In vivo studies have also reported increasing levels of filtration performance and protection factors (in ascending order) for cloth masks, medical masks, and respirators.108112128
There is a large body of experimental evidence supporting the effectiveness of masks and the superiority of respirators, summarized in a review.32 Laboratory based studies have shown low filtration efficiency of surgical masks compared with N95 respirators.32129 Additionally, aerosol studies have reported that the blocking of exhaled aerosols improves with the number of layers of a mask, and is better with a surgical mask than a cloth mask.35 The overall protection factor of N95 respirators was 8-12 times greater than that of surgical masks.130 Protection improves when two or more surgical masks are worn, but is still lower than protection from respirators.131
Use of masks in community for primary prevention
RCTs in community settings
We identified 12 heterogeneous RCTs of facemasks in community settings used for primary prevention in wearers without infection.4849132133134135136137138139140141 Of the primary prevention trials, some showed a protective effect of masks, while others did not. Table 2 summarizes the heterogeneity in settings, interventions, outcomes, and results of these trials. In general, there were low rates of compliance or low incidence of infection. The largest trial, a well designed community RCT in Bangladesh, showed statistically significant protection against symptomatic SARS-CoV-2 infection.49 The data suggest masks are protective in high transmission community settings, especially if used early during epidemics, if combined with hand hygiene, and if wearers are compliant.32 A recently published meta-analysis showed that community mask use compared with no mask use protected against influenza-like or covid-like illness, and against PCR confirmed influenza when masks were combined with hand hygiene.32 The most recent community RCT in Norway showed surgical masks were 29% protective against self-reported respiratory symptoms compared with no mask.141
Summary of high level evidence by GRADE guidelines—clinical trials on facemasks in household setting (adapted and summarized from Greenhalgh et al32 under Creative Commons license)
Observational, case-control, cohort, and laboratory studies in community settings
Observational studies might be affected by confounding and bias and should be interpreted cautiously. However, there are several reasons why these biases would all tend to skew results towards the null.32 Cloth masks were used by the general public during the 1918 influenza pandemic142143 and found to be effective. During SARS in 2002-03, masks were reported to be effective in China, Hong Kong, and Canada where compliance was high.144145146 Several observational and natural experiments have shown masks to be protective in high risk settings.142143144145147 Other than aged care and long term care facilities, the highest risk community setting is households because close, prolonged exposure occurs when an infected family member is present. A household study early in the covid-19 pandemic showed that use of masks in the household reduced the risk of infection by 79% when they were worn before the index case became symptomatic, confirming the role of presymptomatic transmission in outbreaks.148
Mask use was mandatory in many countries during the peak of the covid-19 pandemic and various types of product were used.149 A large, well designed case-control study conducted in California, US during the covid-19 pandemic showed consistent use of any mask in indoor public settings reduced risk of infection, with the highest protection provided by a N95 respirator (83%), followed by a surgical mask (66%), and a cloth mask (56%).150 A range of modeling studies have also shown reduced population transmission.149151152153154 Studies that have used epidemiological approaches to analyzing the effect of mask use during universal masking also suggest protection.155156157
Children
No RCTs of mask use in children were identified, but there is no scientific reason why masks, if worn correctly, would be less effective in this age group. Mask use was protective against influenza in a study in all elementary school children in Matsumoto City, Japan during the 2014-15 influenza season, particularly in children in the higher grade group (9-12 years, grades 4-6).158 One study found that masks reduced a range of respiratory pathogens in school children.159 Another showed that cessation of school mask mandates resulted in a surge of SARS-CoV-2 infection rates.160 In Arizona, US, the odds of covid-19 outbreaks in schools without a mask requirement were 3.5 times higher than those in schools with an early mask requirement (odds ratio 3.5, 95% confidence interval 1.8 to 6.9).161
Other studies during covid-19 generated mixed results.162 Mask acceptance and compliance in children could be low owing to social and physiological factors, including parental and teacher concerns about the impact on speech, language and learning, parental anxiety, and the availability of small size masks.162163164
In August 2020, WHO and Unicef issued guidance on mask use by children and recommended masks only for children aged 5-18 years,165 and that cloth masks should be worn if physical distance of at least 1 m could not be maintained. However, the same policy stated that the age cutoff for wearing a mask should be adapted to social or school settings according to national standards. During the covid-19 pandemic, the US CDC also recommended universal mask use for all students and staff from kindergarten to grade 12.166 During one covid-19 school outbreak when masking for teachers and students was mandatory, one teacher with covid-19 infection removed their mask to read to the class, resulting in a large outbreak, despite spacing of 6 ft (1.83 m) between desks.167
Mask use as source control
Source control is mask use by a person with an infection to protect others. People with acute infection, whether symptomatic or not, might exhale large amounts of highly infectious particles that could be inhaled by others.52 Long range airborne transmission of SARS-CoV-2, for example, has been documented at church events, during choir practice, and on aircraft.168169 Patients with tuberculosis historically have worn masks as source control.
Randomized controlled trials
Four RCTs examined mask use as source control505152170 (table 3). In the first RCT in France, there was no difference between the two arms (medical masks v no masks; odds ratio 0.95, 95% confidence interval 0.44 to 2.05), but the trial finished early because of low recruitment and the subsequent influenza A (H1N1) pandemic in 2009.170 The second RCT was conducted among Hajj pilgrims. Lower rates of symptomatic illness (influenza-like illness) were reported among contacts of pilgrims who used masks (31%) compared with those who did not use masks (53%; P=0.04). However, compliance was low, and laboratory confirmed viral infection was not statistically significantly different between the two groups. The third RCT randomized 245 patients with influenza-like illness presenting to a fever clinic to mask or control arms and observed infection rates in their household contacts.171 No difference between the two groups was found in intention-to-treat analysis, however analysis by actual mask use showed low rates of infection in household contacts of patients who wore masks.171 A fourth RCT quantified the amount of influenza virus and seasonal coronavirus in the exhaled breath of participants with a range of respiratory infections, with and without masks. There was a significant reduction in influenza and coronavirus RNA in exhaled aerosols in the mask group.52 Both these viruses were especially found in small aerosols rather than large droplets, but viral load was low.52Table 3 presents further details of the trials.
Randomized controlled trials on mask use as source control
Other source control studies
An experimental study showed that the spread of influenza virus from an infected patient, measured by coughing onto a Petri dish, might be reduced when the patient wears a facemask or a respirator.172 In this study, nine patients with influenza participated, and each one repeated the experiment with an N95 respirator, a medical mask, and no mask. No virus was detected when an N95 or medical mask was worn for any patient, while seven samples were positive when patients were unmasked. A study on volunteers with influenza reported an almost threefold reduction of viral particles in exhaled breath with the use of medical masks.173 This study also found an almost ninefold higher viral load in fine aerosols compared with larger exhaled particles, supporting evidence that influenza is an airborne virus. During the SARS outbreak, medical and cloth masks were used as source control and reported to be effective.105 A recent study showed that all types of face covering (cloth masks, surgical masks, and respirators) reduce SARS-CoV viral load in exhaled breath of volunteers with covid-19. However, N95 respirators were superior to other face coverings, even when used without training and fit testing.174 There is also evidence that use of facemasks reduces the risk of tuberculosis transmission in people with the disease.175 Despite the lack of human clinical trial data, medical masks are recommended by WHO, the CDC and the European Centre for Disease Prevention and Control to use as source control for patients with tuberculosis.176177178
Selection of masks or respirators
Occupational health and safety factors
The occupational health and safety hierarchy of controls rates removal of the worker from the hazard or substitution of the hazard as more important than personal protective equipment (PPE).179 However, unlike construction workers and other workers where the hazard (such as a faulty ladder) is incidental to the job, for a health worker, the hazard is the job itself; they must treat patients with deadly infectious diseases, and removal of these patients or substitution of them is clearly not an option. This context and the importance of respirators for health workers has never been explicitly recognized. Infection prevention and control guidelines traditionally consider only assumed mode of transmission, but a risk based approach is recommended that considers the pathogen, the setting, the occupational health and safety requirements, availability of treatment or vaccines, and uncertainty.180Figure 2 presents a model for considering host, pathogen, and organization.181 Availability of masks and respirators is one of the most important organizational factors, particularly in low resource settings or during global PPE shortages, so organizations should ensure adequate supplies of respirators for frontline staff.182 The precautionary principle should be used if a disease has high morbidity and mortality, or for a newly emerging infection with unknown impact or high risk of nosocomial infection.183 Risk perception, cultural background, discomfort, immune status, and pre-existing illness of the wearer might also influence use of masks and respirators.184 When risk perception is high, compliance will be higher, so studies of masks conducted during low risk periods might not reflect actual compliance during a pandemic.185
Multifactorial approach to selection of masks and respirators in healthcare settings
Fit testing of respirators
Fit testing is important for respirators, which can be done using qualitative or quantitative methods.186 For maximum protection, a respirator should fit the face and there should be no gap between the face and the respirator. Facial fit depends on face shape, shape of respirators (dome shape v duckbill shape), and type of straps (head straps v ear loops). Ear loops have poorer fit than head straps. Fit factors for respirators with ear loops (KN95) are lower compared with respirators with head straps.187 However, respirators might interfere with breathing owing to a build up of carbon dioxide inside the facepiece, particularly in people with pre-existing lung conditions such as asthma and chronic obstructive pulmonary disease.188189 Therefore, medical evaluation is a part of a respiratory protection programme and is highly recommended before the use of respirators for people with chronic obstructive pulmonary disease or other relevant medical conditions.190 A physician or other licensed healthcare professional should perform a medical evaluation of employees and keep records for follow-up.
Mask mandates, universal masking, and situational considerations
Mask policies might vary over time during the same epidemic, or situationally. Guidelines might recommend masks only for people who are sick, or for healthy people (universal masking, such as during mask mandates), or for specific settings or specific times. One of the key determinants of the value of community masking during pandemics or serious epidemics is asymptomatic or presymptomatic transmission. Asymptomatic transmission of influenza has long been recognized, but SARS-CoV-2 has a much higher degree of asymptomatic transmission.191 It is estimated that 30-50% of SARS-CoV-2 transmission is asymptomatic.191192 In one study, around 44% (95% confidence interval 30% to 57%) of secondary infections occurred during the presymptomatic stage191; this means that, in a high risk setting, people who are sick or healthy cannot self-identify risk of exposure in a crowded public setting unless testing is done.193194195 This is one of the strongest justifications for mass masking during epidemic waves of SARS-CoV-2. Special consideration is needed for high risk settings such as hospitals and aged care facilities. Nosocomial covid-19 is a major, ongoing problem, with a high mortality rate.196 Masking of staff in clinical areas can reduce this risk. One study showed that during the covid-19 pandemic, facilities that started universal staff masking had smaller epidemics than those that did not.78 Nosocomial influenza risk was also reduced by 50% with mask mandates.197 The covid-19 pandemic also highlighted the importance of asymptomatic, presymptomatic, and early symptomatic transmission, which is a rationale for universal masking in high risk settings or during periods of high community transmission.
Non-standardized practices around mask use during epidemics or pandemics
PPE shortages might occur during pandemics, as seen during the H1N1 pandemic in 2009 and the covid-19 pandemic. Non-standardized practices, such as extended use and reuse of masks and respirators, double masking, and use of cloth masks in healthcare, were seen during the covid-19 pandemic.198199200 Knotting of the ear loops around the ear and tucking around the face, and double masking, might also improve fit and filtration effectiveness.201 Double masking can be done in various combinations, such as cloth covering the medical mask,201 cloth or medical mask over a N95 respirator, or using two medical masks. The aim of using an additional mask is to protect the underlying mask or improve filtration and fit, however this could reduce breathability, resulting in greater discomfort. A simulation study reported more than 85% reduction in the spread of particles emitted during a cough when a three ply cloth mask was used over a three ply medical procedure mask.201
Extended use and reuse of masks and respirators
In situations of shortages, or where cost is a limitation, or to reduce waste, extended use and reuse could be considered. The US CDC provides guidance on extended use and reuse, as well as conventional, contingency, and crisis capacity strategies.202 However, there is no standard definition of extended use and reuse of masks and respirators.203204 Disposable masks are worn for up to eight hours, or during a shift, unless soiled, wet, or damaged. Extended use of a respirator refers to wearing the same N95 respirator or mask longer than the recommended usage time, without removing it between patient encounters.203 Reuse is defined as using the same N95 respirator or mask for several patient encounters with removal and reapplication after encounters.203
There is limited evidence around the safety of these practices and guidelines are inconsistent.205 Pathogens might be present at the outer or inner mask surfaces206 and this could increase the risk of self-contamination. Moreover, extended use could lead to reduction in humid air filtration efficiency.207 Frequent hand washing is recommended for extended use and reuse, and products should be adequately stored for reuse. Finally, facial fit might be lost after prolonged use of respirators, especially trifold shape respirators compared with dome and duckbill shaped. A study in the US showed high rates of fit testing failure after reuse of N95 respirators by healthcare workers, increasing from 38.7% after the first shift of wear to 92.8% after five shifts.208 Various cleaning and disinfection methods for reusing disposable products have been studied, including soap and water, bleach, autoclave, isopropyl alcohol, vaporized hydrogen peroxide, ultraviolet germicidal radiation, ethylene oxide, microwave oven irradiation, steam, and dry heat.209210211212 However, most of these methods could degrade disposable masks. A systematic review found vaporized hydrogen peroxide and ultraviolet germicidal irradiation were the most effective decontamination methods.205
Use of cloth masks
Owing to shortages of disposable masks during the covid-19 pandemic, extensive research on improving the performance of cloth masks was conducted.90213214215216217 Cloth masks are commonly used, particularly in low resource countries, and until the covid-19 pandemic were ignored in policy documents, which all assumed adequate supplies of disposable masks.182 A range of options were used in early 2020, including single or double layer masks, neck gaiters, and bandanas. During covid-19, cloth masks, homemade face coverings, or a scarf or bandana were also recommended and widely used.36 Some observational studies showed they are effective, albeit less than medical masks and respirators.218 A large body of research was conducted in 2020 on last resort strategies for masking, including optimal design of cloth masks. One published RCT of cloth masks showed that they performed poorly.45 Cloth masks might be harmful if not washed daily in hot water owing to moisture retention and contamination accumulation. Analysis of data on washing from a cloth mask trial showed that if washed in a washing machine at high temperature, the cloth masks performed as well as surgical masks, but that poorly washed cloth masks are ineffective.90 Washing can also improve filtration of cloth masks by shrinking pore size.213219
In vivo studies show low filtration efficacy and high particle penetration for cloth masks, ranging from 40% to 90%.107220 A comprehensive study of fit, layers, fabric, washing, and water resistance showed that a high performing cloth mask could be designed.213219 However, cloth masks should not be used in healthcare settings; they could be used in community settings during shortages.
Emerging areas in mask design
The protection function of masks or respirators is related to design, material, and proper use, and more research is needed in all these areas. The design of masks should be improved for proper fit to the face, as well as for easy donning and doffing. A loosely fitted respirator could provide the same protection as a medical mask, while a tightly sealed medical mask or respirator will significantly improve the protection.221 Doffing is a high risk procedure with a risk of self-contamination during doffing, and mask design should enable safer doffing.222 New fabrics should be tested to improve comfort and to minimize adverse events associated with mask or respirator use. Many new designs and fabrics of masks were tested during the covid-19 pandemic to improve comfort, reduce contact transmission, and ease breathing.223224225 However, data are limited on the effectiveness of these methods.
Guidelines
Table 4 shows current guidelines on mask use in healthcare and community settings for selected infections. In healthcare settings, masks and respirators are generally chosen based on assumed transmission mode of pathogens because most guidelines on the use of masks and respirators in respiratory diseases were written wholly or predominantly from the infection prevention and control model of infections being classified as droplet or airborne. This policy assumes most transmission is by large droplets, with hazard being present only in close proximity (1-2 m) or during aerosol generating procedures. This belief might be based on experiments from the 1950s, which suggest that droplets are large in size (10-100 µm) and do not travel more than 1-2 m.251 In fact, droplets with a diameter of more than 10 µm can be suspended in the air252 and large droplets can travel further than 2 m, in some cases up to 8 m.253 Large and small respiratory particles are a continuum and both occur at short and long range.254 Therefore, an aerosolized pathogen can be inhaled at a shorter or longer distance and might cause infection, and a facemask would not offer sufficient protection from inhalation risk.251 According to most infection control guidelines, influenza is assumed to be transmitted through large droplets, but there is ample evidence of airborne transmission of influenza.255 SARS-CoV-2 was initially thought to be transmitted through droplets, but is now accepted to be airborne.256 Moreover, most pathogens transmit through more than one route and the relative contribution of each mode is difficult to quantify.251 In 2024, WHO also moved away from classifying transmission as droplet or airborne, and acknowledged a continuum of respiratory particles in air of various sizes at close and long range. Respirators are designed to protect against inhaled pathogens spread by the airborne route and should be recommended in closed indoor settings where transmission risk is high.
Current guidelines on use of masks or respirators to protect from selected infectious diseases. Guidance from: World Health Organization (WHO), Centers for Disease Control and Prevention (CDC), European Centre for Disease Prevention and Control (ECDC), and National Health Service (NHS) England, UK Health Security Agency (HSA)
Summary of evidence and recommendations
Conflict and controversy about masks and respirators is not new—before covid-19, it occurred during the 2003 SARS epidemic, the 2009 influenza pandemic, and the 2014 Ebola epidemic.180181257 The sum of evidence shows that masks and respirators offer protection against respiratory infections. The covid-19 pandemic resulted in intensive research on masks and respirators, which added further evidence to the existing body of RCTs, observational and experimental evidence.32 The evidence shows that respirators offer better protection than masks, but that any protection is better than none during a pandemic or serious emerging respiratory infection. There was also new research during the covid-19 pandemic that highlighted the false dichotomy of droplet versus airborne transmission, and provided new insights into aerosol transmission of viruses and the resulting inhalation risk in indoor environments.32 Evidence from community and experimental studies shows that protection increases from cloth masks to surgical masks to N95 respirators.150 The effectiveness is subject to compliance and if used early in an epidemic.
Hand hygiene should be used for donning and doffing of a mask, with one study showing protection of masks only when combined with hand hygiene.139 RCTs that showed low or no community efficacy of masks by intention-to-treat analysis generally had low compliance with mask wearing. Compliance is a function of risk perception, which might increase during serious epidemics—meaning that RCTs conducted during low risk periods and with low compliance might not reflect actual protection during a pandemic when compliance would be higher.
Current community guidelines for SARS-CoV-2 have a disproportionate focus on the use of masks as source control only for people with symptoms. This is inadequate for infections with significant asymptomatic or presymptomatic transmission, such as SARS-CoV-2 and influenza. For this reason, in high risk, high transmission settings, such as aged care facilities or hospitals, universal masking is more effective.78 For infections like SARS-CoV-2 with substantial transmission in the asymptomatic or presymptomatic period, universal masking can have a major impact on flattening the curve, while masks for source control would have less impact.258 The dramatic decline in other respiratory viral infections such as influenza as a result of covid mitigations such as masks in 2020 is a real world demonstration of effectiveness.259
Mask policies are commonly static and fail to consider changing epidemiology and risk. We suggest a multifactorial approach to policies around mask use, which consider specific characteristics of the pathogen, degree of asymptomatic transmission, host and organization, as well as context and disease epidemiology. Epidemic and pandemic infections are dynamic in nature, and use of masks and respirators should be tailored to the situational epidemiology. For example, SARS-CoV-2 has had several epidemic waves since it emerged, with periods of lower incidence between waves. A rising wave of a serious epidemic or pandemic can be a trigger for community masking. A stepwise plan for community masking could also be devised for serious epidemics, which might include earlier and ongoing masking for high risk settings such as hospitals and aged care; masking on public transport and in crowded public spaces; and reserving community wide mandates as a last resort. Figure 3 provides a schema for a stepwise plan, and shows that for healthcare and aged care, as well as other long term care facilities, masking should start earlier and continue for longer.
Stepwise plan for mask use
The highest priority is around healthcare workers, whose occupational health must be protected to ensure their safety, as well as integrity and effectiveness of health system capacity during an epidemic. High risk environments like healthcare and aged care should have agile policies that consider the pathogen, asymptomatic transmission, the level of community transmission, and the occupational safety of workers. Prevention of nosocomial outbreaks should be a goal, and a lower threshold for use of universal masking for staff and visitors should exist for aged care and healthcare during periods of high community transmission of infections like SARS-CoV-2. Research to develop new hierarchies of control in occupational medicine for staff who treat patients with infection is also needed, as the current version was developed around physical injuries, and assumes hazards in the workplace are incidental to the job and can be removed or modified. They fail to account for healthcare workers, for whom the infectious patient is the hazard.
Respirators should be used for healthcare workers when the disease is severe with high case fatality rate, when healthcare worker absenteeism would affect health system functioning, or when no drug or vaccine is available.181 During emerging pandemics, healthcare workers face the hazard of a new infection as a non-negotiable part of their job, which differs from a construction worker, who might face hazards (such as faulty equipment) that can be removed or replaced. Additionally, during a pandemic, organizational changes might not occur fast enough for other protections, such as changes to ventilation systems. As such, PPE might be the only available protection for healthcare workers. The precautionary principle should be used during serious epidemics, a key lesson articulated in the aftermath of SARS in Canada, where a large, fatal outbreak occurred in Toronto, with healthcare workers refused N95 respirators.260 By contrast, Vancouver, where healthcare workers were provided N95s, did not have an outbreak, despite Toronto and Vancouver having their first SARS case at the same time. Unfortunately, that lesson was not learnt during the SARS-CoV-2 pandemic 17 years later, where the same disagreements about masks and respirators occurred and many healthcare workers died.261 The evidence from healthcare supports N95 use, but continuously rather than occasionally in self-identified situations of risk.32 This will require a major paradigm shift because guidelines to date recommend targeted use of respirators in very select situations. Targeted N95 use might be a cost saving measure, rather than evidence based policy, but all health systems must adequately cost occupational safety measures for their staff. In fact, studies suggest using cheaper, less effective masks, which might end up being costlier in the long run for hospitals.262Figure 4 shows a decision tree for selecting mask or respirator use in various settings based on available evidence, which might assist organizations or health providers.
Decision tree for selecting mask or respirator use in various settings to protect from respiratory infections. *Pathogens with high epidemic activity or high consequence pathogen
Research gaps and the way forward
More research is needed to address research gaps (box 1). Research on sustainable and reusable products will help overcome acute shortages during emergencies, as will research and clear guidelines on contingency and crisis strategies such as reuse, extended use, and disinfection of disposable products. Effectiveness of non-standardized practices should also be studied, including the use of cloth masks, mask reuse, extended use, and double masking. Gaps remain in research on cost effectiveness to inform stockpiling of PPE for pandemics, as shortages occur during every pandemic. Stockpiling for pandemics has been inadequate during SARS-CoV-2 and the 2009 influenza pandemic, with global shortages of PPE early in each pandemic. Modeling and health economic studies might assist governments to stockpile effectively. A study during covid-19 reported the cost effectiveness of N95 respirators in terms of reducing hospital acquired infections and deaths, and a reduction in patient bed days and staff replacement needs.263 Another study showed that N95 respirators in healthcare can be cost effective, but more studies would assist with choices in the healthcare sector, and for pandemic planning and stockpiling.264265 Finally, strategies should be developed to improve compliance with the use of masks in healthcare and community settings. Most of the observational studies on mask use were conducted during epidemics and pandemics when compliance is generally high because of mask mandates or high risk perception. Compliance might be lower in routine occupational settings such as hospitals or aged care facilities, but proactive, early mask use in such settings is shown to reduce outbreaks.
Suggested directions for further research
-
Research on effective health communication, health promotion, and countering disinformation
-
Effectiveness of non-standardized practices, including cloth mask use, mask reuse, extended use, and double masking, and methods to clean and disinfect masks and respirators for reuse
-
Research to develop new materials and designs for sustainable and reusable masks and respirators for community and healthcare use
-
Research and develop new hierarchies of control in occupational medicine in the context of health workers and serious infections where avoidance and substitution are not possible for a clinician treating patients with infection
-
Research on masks for population groups with special needs, such as children, people with hearing impairment, people with respiratory, neurocognitive or psychiatric illness, and other groups
-
Modeling studies to inform better stockpiling by governments and hospitals
-
Comprehensive economic evaluation analyses of facemasks incorporating clinical efficacy estimates applied to different settings such as healthcare, aged care, and community
RETURN TO TEXT
Community engagement, especially around healthcare, aged care, and groups that have difficulty with masking such as children, those with hearing impairments, or people with chronic obstructive pulmonary disease is also key to developing mask policy. Countering disinformation and politicization of masks will also assist in preparedness for future pandemics. The discrepant and rapidly changing mask policies seen during covid-19 are concerning because the available evidence was adequate at the start of the pandemic. This suggests that ideology, lack of understanding of the available evidence, short supply and cost, rather than evidence, drove this inconsistency. In fact, contradictory mask policies during covid-19 (such as not recommending masks at the beginning of the pandemic and then recommending N95s for community settings by the US CDC) might have contributed to loss of public trust.25 If health leaders are seen to hesitate, or lack knowledge or confidence, then confidence in the pandemic response might be eroded. There has been a backlash against public health measures in general, including masks and vaccines after the covid-19 pandemic.266267 Widespread disinformation has polarized communities about masks, which have become a stigmatizing political symbol rather than a simple public health measure.268 More research is needed on effective health communication and countering disinformation.
Some population groups might have difficulty using masks, including children, people with hearing impairment, cognitive impairment, chronic respiratory impairment, or mental illness. These groups should be considered for exemptions or other solutions and protective strategies. For example, clear masks or masks with clear panels might aid communication for people with hearing impairment.
Limitations of review
There are limitations of this review. RCTs on mask use are difficult to conduct for many reasons, such as unpredictable incidence of infection in the community, low compliance with masks, measurement of outcomes, complexity of follow-up, the statistical power needed to study relatively rare outcomes, and the lack of control groups for ethical reasons.34 The available RCTs are heterogeneous in settings (eg, household v healthcare), design (eg, individual v cluster randomization), interventions (eg, continuous v intermittent use), and outcome measures (eg, serology v PCR testing). Therefore, meta-analysis of these RCTs can be misleading if they combine data from trials with heterogeneous interventions and outcomes. To address this issue, recently we performed meta-analyses of RCTs in healthcare and community settings, including studies with similar settings, interventions, and outcome measures, showing that respirators perform the best.32 Another limitation of this review is including only English language publications. During covid-19, many studies were conducted globally on masks and respirators, which might not be included in this review. Finally, one author (CRM) has conducted a large body of RCTs on mask use in healthcare and community settings, so our own work is cited in this paper. However, all other published RCTs to 2024 are included in this review (table 1, table 2, table 3).
Conclusion
In conclusion, there is ample evidence on the effectiveness of masks and respirators in community and healthcare settings to inform consistent policy.32 Respirators are superior and should be the first choice in a serious emerging epidemic or pandemic in healthcare and aged care settings. Community mask use is effective when risk is high or during periods of increased community transmission of pathogens, especially among those who are asymptomatic. The pathogen, host, and organizational context should all influence policy, which should be flexible to changing disease epidemiology. Strong leadership is required to overcome politicization and polarization around masks. The unprecedented global spread of avian influenza A (H5N1 clade 2.3.4.4b) since 2021 and the increasing risk of a human pandemic make it imperative that governments take steps to stockpile, prepare and develop sound guidelines, provide health leadership, and address disinformation.
Acknowledgments
Contributors: CRM: conception and design, leading of the writing, worked on RCT and non-RCT evidence, manuscript writing; AAC: conception and design, initial data collection, prepared first draft of manuscript; MK: worked on meta-analysis section, contributed to manuscript writing; ET: worked on policy section, contributed to manuscript writing; TG: worked on RCT and non-RCT evidence, contributed to manuscript writing.
Footnotes
-
State of the Art Reviews are commissioned on the basis of their relevance to academics and specialists in the US and internationally. For this reason they are written predominantly by US authors.
-
Competing interests: We have read and understood the BMJ policy on declaration of interests and declare the following interests: CRM has in the past received funding for investigator driven research on facemasks from 3M in the form of an Australian Research Council Industry Linkage grant in 2010 (where 3M was the industry partner) and supply of masks for clinical research. She has been on an advisory board for mask manufacturer, Ascend and conducted clinical research study with them. She has also received funding or in-kind support from Detmold, Sanofi, GSK, Merck, BioCSL, and Pfizer for investigator driven research on infectious diseases. TG is a member of Independent SAGE. She has previously received funding from Wellcome Trust and UK National Institute for Health Research on pandemic related research (including rapid reviews of masks). In the past three years, TG has received grants from the UK National Institute for Health Research, Balvi, the Medical Research Council, Health Data Research UK, and Research Council of Norway. She is a governing body fellow of Green Templeton College, Oxford; and a Visitor at the Pitt Rivers Museum, Oxford; and was previously a Trustee and advisor to the Hilda Martindale Charitable Trust. TG is also a member of Independent SAGE. The other authors declared no conflict of interest.
-
Provenance and peer review: Commissioned; externally peer reviewed.
References
- ↵
- ↵
- ↵
- ↵
- ↵
- ↵
- ↵
- ↵
- ↵
- ↵
- ↵
- ↵
- ↵
- ↵
- ↵
- ↵
- ↵
- ↵
- ↵
- ↵
- ↵
- ↵
- ↵
- ↵
- ↵
- ↵
- ↵
- ↵
Jefferson T, Dooley L, Ferroni E, Al-Ansary LA, van Driel ML, Bawazeer GA, et al. Physical interventions to interrupt or reduce the spread of respiratory viruses. Cochrane Database Syst Rev 2023;1.
- ↵
- ↵
- ↵
- ↵
- ↵
- ↵
- ↵
- ↵
- ↵
- ↵
- ↵
- ↵
- ↵
- ↵
- ↵
- ↵
- ↵
- ↵
- ↵
- ↵
- ↵
- ↵
- ↵
- ↵
- ↵
- ↵
- ↵
- ↵
- ↵
- ↵
- ↵
- ↵
- ↵
- ↵
- ↵
- ↵
- ↵
- ↵
- ↵
- ↵
- ↵
- ↵
- ↵
- ↵
- ↵
- ↵
- ↵
- ↵
- ↵
- ↵
- ↵
- ↵
- ↵
- ↵
- ↵
- ↵
- ↵
- ↵
- ↵
- ↵
- ↵
- ↵
- ↵
- ↵
- ↵
- ↵
- ↵
- ↵
- ↵
- ↵
- ↵
- ↵
- ↵
- ↵
- ↵
- ↵
- ↵
- ↵
- ↵
- ↵
- ↵
- ↵
- ↵
- ↵
- ↵
- ↵
- ↵
- ↵
- ↵
- ↵
- ↵
- ↵
- ↵
- ↵
- ↵
- ↵
- ↵
- ↵
- ↵
- ↵
- ↵
- ↵
- ↵
- ↵
- ↵
- ↵
- ↵
- ↵
- ↵
- ↵
- ↵
- ↵
- ↵
- ↵
- ↵
- ↵
- ↵
- ↵
- ↵
- ↵
- ↵
- ↵
- ↵
- ↵
- ↵
- ↵
- ↵
- ↵
- ↵
- ↵
- ↵
- ↵
- ↵
- ↵
- ↵
- ↵
- ↵
- ↵
- ↵
- ↵
- ↵
- ↵
- ↵
- ↵
- ↵
- ↵
- ↵
- ↵
- ↵
- ↵
- ↵
- ↵
- ↵
- ↵
- ↵
- ↵
- ↵
- ↵
- ↵
- ↵
- ↵
NIOSH. Hospital Respiratory Protection Program Toolkit: Resources for Respirator Program Administrators. Atlanta, GA: Department of Health and Human Services, Centers for Disease Control and Prevention, National Institute for Occupational Safety and Health, DHHS (NIOSH). Publication Number 2015-117. 2015; revised April 2022. Available from: doi:https://doi.org/10.26616/NIOSHPUB2015117revised042022
- ↵
- ↵
- ↵
- ↵
- ↵
- ↵
- ↵
- ↵
- ↵
- ↵
- ↵
- ↵
- ↵
- ↵
- ↵
- ↵
- ↵
- ↵
- ↵
- ↵
- ↵
- ↵
- ↵
- ↵
- ↵
- ↵
- ↵
- ↵
- ↵
- ↵
- ↵
- ↵
- ↵
- ↵
- ↵
- ↵
- ↵
- ↵
- ↵
- ↵
- ↵
- ↵
- ↵
- ↵
- ↵
- ↵
- ↵
- ↵
- ↵
- ↵
- ↵
- ↵
- ↵
link